Literature DB >> 22703915

The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Keith Duffy1, Douglas Grossman.   

Abstract

Since its description in the 1970s, the dysplastic nevus has been a source of confusion, and whether it represents a precursor to melanoma remains a controversial subject. Although a Consensus Conference in 1992 recommended that the term "dysplastic nevus" no longer be used, the histologic diagnosis continues to present a therapeutic quandary for dermatologists and other physicians, and there remains significant variation in clinical management. In part I of this continuing medical education review, we will discuss the historical origins of the term, the evidence for its distinct histologic basis, and its clinical significance.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22703915      PMCID: PMC3625372          DOI: 10.1016/j.jaad.2012.02.047

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  122 in total

Review 1.  Dysplastic naevi--an alternative view.

Authors:  M G Cook; M E Fallowfield
Journal:  Histopathology       Date:  1990-01       Impact factor: 5.087

2.  Histologic atypia in clinically benign nevi. A prospective study.

Authors:  L J Klein; R J Barr
Journal:  J Am Acad Dermatol       Date:  1990-02       Impact factor: 11.527

3.  Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.

Authors:  K Jimbow; T Horikoshi; H Takahashi; Y Akutsu; K Maeda
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

4.  Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma.

Authors:  R Marks; A P Dorevitch; G Mason
Journal:  Australas J Dermatol       Date:  1990       Impact factor: 2.875

5.  Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis.

Authors:  S B Gruber; R L Barnhill; K S Stenn; G C Roush
Journal:  J Am Acad Dermatol       Date:  1989-10       Impact factor: 11.527

6.  Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group.

Authors:  I Ahmed; M W Piepkorn; M S Rabkin; L J Meyer; M Feldkamp; D E Goldgar; M H Skolnick; J J Zone
Journal:  J Am Acad Dermatol       Date:  1990-05       Impact factor: 11.527

7.  Histologic correlations with the clinical diagnosis of dysplastic nevus.

Authors:  W C Black; W C Hunt
Journal:  Am J Surg Pathol       Date:  1990-01       Impact factor: 6.394

8.  Yield from total skin examination and effectiveness of skin cancer awareness program. Findings in 874 new dermatology patients.

Authors:  G Lee; M C Massa; S Welykyj; J Choo; V Greaney
Journal:  Cancer       Date:  1991-01-01       Impact factor: 6.860

9.  Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.

Authors:  A R Rhodes; M C Mihm; M A Weinstock
Journal:  Mod Pathol       Date:  1989-07       Impact factor: 7.842

10.  Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.

Authors:  G D Masri; W H Clark; D Guerry; A Halpern; C J Thompson; D E Elder
Journal:  J Am Acad Dermatol       Date:  1990-06       Impact factor: 11.527

View more
  18 in total

1.  Expression of Bcl-2, Melan A and HMB-45 in Dysplastic Nevi.

Authors:  Oana Maria Patrascu; Mariana Costache; Adrian Vasile Dumitru; Corina Nicoleta Mehotin; Maria Sajin; Anca Mihaela Lazaroiu
Journal:  Maedica (Bucur)       Date:  2016-03

2.  Melanoma risk stratification of individuals with a high-risk naevus phenotype - A pilot study.

Authors:  Ayelet Rishpon; Cristian Navarrete-Dechent; Ashfaq A Marghoob; Stephen W Dusza; Gila Isman; Kivanc Kose; Allan C Halpern; Michael A Marchetti
Journal:  Australas J Dermatol       Date:  2019-04-02       Impact factor: 2.875

3.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

Review 4.  Dysplastic nevi and melanoma.

Authors:  Alisa M Goldstein; Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

Review 5.  [Dysplastic melanocytic nevus].

Authors:  E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 6.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

Review 7.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

8.  Nuclear and cytoplasmic features in the diagnosis of Clark's nevi.

Authors:  Manuel Valdebran; Justin Bandino; Amira Elbendary; Abdallah Gad; Krishna C Arudra; Sébastien de Feraudy; Dirk M Elston
Journal:  J Cutan Pathol       Date:  2017-12-28       Impact factor: 1.587

9.  The so-called dysplastic nevus is not dysplastic at all.

Authors:  Raman Madan; Sheng Chen
Journal:  Dermatol Pract Concept       Date:  2013-01-31

10.  High-definition optical coherence tomography imaging of melanocytic lesions: a pilot study.

Authors:  Marc A L M Boone; Sarah Norrenberg; Gregor B E Jemec; V Del Marmol
Journal:  Arch Dermatol Res       Date:  2013-07-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.